Case study · GP-led hair rejuvenation

Managing perimenopausal hair loss — compounded by rapid weight loss.

A real, GP-led case: a holistic approach to hormonally-driven hair thinning, combining full medical assessment with exosome-based regenerative therapy.

Dr Raghda Elghazawy
Dr Raghda Elghazawy — treating GP.
First published by DermaFocus (Regenerative Aesthetics).

Hair loss in midlife women is common yet under-recognised. The perimenopausal transition brings fluctuating, ultimately declining oestrogen, relative androgen predominance, metabolic change and heightened physiological stress — together disrupting the hair-growth cycle and causing diffuse thinning, finer hair and increased shedding. It is rarely driven by one thing alone.

In recent years, GLP-1 medications for weight management have added another dimension: rapid weight loss is a well-documented trigger for telogen effluvium. Against a background of perimenopausal change, the combined effect on hair density — and on how a patient feels — can be profound. A single-modality, purely cosmetic approach is often not enough; a GP-led strategy that treats the whole picture is more appropriate.

Diagram of thinning across the crown and temples
Patient profile

A 40-year-old woman, thinning at the crown and temples.

  • Age
    40
  • Presenting concern
    Progressive diffuse thinning across the crown and frontal scalp, visible scalp show-through, and a female-pattern parting.
  • History
    Perimenopausal symptoms; hair loss began in perimenopause and accelerated after significant weight loss on a GLP-1 medication.
  • Impact
    Increased shedding when washing and brushing; reduced hair strength and diameter; significant distress and fear the loss might be permanent.
Treatment planning · GP-led

A whole-body approach, not just the scalp.

Recognising the interplay between systemic health and follicular function, the plan combined medical optimisation, adjunctive scalp care, and a targeted, non-hormonal regenerative treatment — chosen with the patient’s preference to avoid hormonal or systemic therapies.

i.

Medical optimisation

Bloods to assess the common reversible drivers, with correction planned where needed:

  • Iron / ferritin
  • Vitamin D
  • Vitamin B12
  • Thyroid function

In this case, no deficiencies were identified.

ii.

Adjunctive scalp & lifestyle

  • Caffeine-based shampoo to support scalp circulation
  • Intermittent ketoconazole shampoo to reduce subclinical inflammation
  • Daily multivitamin through the recovery phase
iii.

Regenerative therapy

A non-hormonal, exosome-based treatment — Purasomes HSC50+ Hair & Scalp Complex — delivered via microneedling-assisted application to support the follicular environment and signalling. 3 sessions, across the crown and frontal scalp.

The regenerative rationale

Supporting the follicle, not suppressing hormones.

Exosome-based treatments aim to modulate the follicular microenvironment — influencing inflammation, stem-cell signalling and anagen maintenance — rather than acting on hormonal pathways. That makes them well-suited to hormonally-influenced but non-destructive hair loss, where follicles remain viable but functionally impaired.

177%↑ proliferation index
115%↑ IGF-1 production
500%↑ miRNA-31 expression

Figures over four weeks, from the manufacturer’s cited research for Purasomes HSC50+, alongside reductions in scalp redness and transepidermal water loss. Presented as published evidence, not a guarantee of individual results.

Purasomes HSC50+ vial
Results

Before & after.

Improvement in scalp coverage and hair calibre across the crown and frontal scalp — progressive and incremental, in line with normal hair-growth physiology rather than an acute cosmetic change.

BEFORECrown and parting before treatment
AFTERCrown and parting after treatment
BEFOREFrontal hairline before treatment
AFTERFrontal hairline after treatment
I was really worried my hair loss was permanent, especially with perimenopause and after losing weight. Having a doctor take a whole-body approach — not just focus on my scalp — was very reassuring. The shedding reduced first, and over time my hair has felt stronger and fuller. I finally feel hopeful again.
The patient · in her own words
Microneedling-assisted scalp treatment
Clinical assessment

On review, there was visible improvement in scalp coverage and hair calibre, particularly across the crown and frontal scalp — consistent with improved follicular activity and re-entry into the growth (anagen) phase.

Results were incremental and aligned with the expected timeline for recovery in non-scarring, hormonally and stress-related hair loss. The patient continues to be monitored, with continued optimisation of nutrition, hormonal health and lifestyle central to long-term management.

Concerned about thinning or shedding?

Book a hair consultation

This case study describes one patient’s course and outcome. Hair loss has many causes and responses vary from person to person; results are not guaranteed. Every plan starts with a GP-led assessment of what is actually driving your hair loss — including whether treatment is the right next step. The full case study is available on Instagram.